Denosumab plus romosozumab vs denosumab only was associated with improved bone mineral density among patients with severe postmenopausal osteoporosis.

Sodium-glucose cotransporter 2 (SGLT2) inhibitor use is an independent risk factor for falls in people with type 2 diabetes.

Patients with psoriatic arthritis (PsA) have delays in diagnosis compared with those with rheumatoid arthritis (RA).

Total hip BMD increases were associated with reduced risk for vertebral and all clinical fractures across active control or sequential therapy trials.

Vitamin D supplementation during pregnancy was not associated with any effects on maternal bone mineral density at 4-year follow-up.

Children receiving multiple antibiotic courses between birth and age 2 years may have a higher risk for some chronic conditions.

Across the globe, children with RF-negative polyarticular JIA exhibit differences in clinical features, disease activity, and treatment patterns.

Combination rituximab and IVIG therapy may be a viable treatment option for patients with refractory autoimmune diseases, though the quality of evidence is low.